Catalog

Aminopterin embryofetopathy

No MMS code

Link to WHO Definition

Aminopterin embryofetopathy – http://id.who.int/icd/entity/492190859

Aminopterin/Methotrexate embryofetopathy is a syndrome of developmental anomalies characterised by growth deficiency, facial dysmorphism and skull, limb and neural defects secondary to maternal exposure to aminopterin or methotrexate (MTX) during pregnancy.